![]() Use of methamphetamine is associated with multiple morbidities, including: psychiatric symptoms (hallucinations, delusions, anxiety, and depression), physical concerns (hypertension, increased risk of intracranial hemorrhagic stroke, cardiomyopathy, renal failure, ischemic heart disease), and increased risk of suicide and injury. Despite the higher rates of use in rural counties compared to urban, most methamphetamine research in the USA has been conducted with urban sexual minorities in the context of HIV prevention research and has not sufficiently explored the phenomenon of methamphetamine use among other populations of users. In the USA, rural and non-metro counties typically have far fewer substance use disorder treatment, harm reduction, and healthcare services, making adequate response to drug-related morbidity and mortality more difficult. ![]() Following earlier trends in opioid-related morbidity and mortality, where initial increases were most dramatic in smaller rural communities, rural and non-metro counties have also seen the largest increases in methamphetamine use per capita. In fact, the USA experienced a 198% increase in use of amphetamine type stimulants between 20, driven primarily by methamphetamine. ![]() In 2019, an estimated 27 million persons worldwide used methamphetamine, with the highest prevalence occurring in North America. The UN Office on Drugs and Crime has been noting increasing use of amphetamine type stimulants, particularly methamphetamine, for over a decade. Since then, methamphetamine use has been expanding in other regions of the globe. In the early 2000s, the highest prevalence of methamphetamine use was in Asian Regions. Among amphetamine type stimulants, the most widely and commonly used is methamphetamine. Addressing this current wave of drug-related deaths will require attention to the multiple factors that structure experiences of methamphetamine “overdose,” and a collaborative effort with PWUDs to devise effective harm reduction and treatment strategies.Īmphetamine type stimulants account for a significant share of illicit drug use globally. However, they described a number of undesirable symptoms associated with overconsumption of methamphetamine and had few clinical or harm reduction strategies at their disposal. When asked directly, our respondents claimed that acute, fatal methamphetamine overdose is rare or even impossible. ![]() General self-care strategies such as sleeping and staying hydrated were discussed. Few reported seeking medical attention for undesirable effects (usually related to psychological effects). Reports of acute, fatal methamphetamine overdose were rare. Respondents described a constellation of psychological and physical symptoms that they characterized as “overamping,” experienced on a continuum from less to more severe. Interviews were recorded, transcribed, and analyzed using qualitative thematic analysis. We conducted 21 qualitative interviews with people over the age of 18 who reported using methamphetamine in the previous 3 months in Nevada and New Mexico. In the current study, we explore qualitative narratives of methamphetamine overdose and strategies used by people who use drugs to reduce the undesirable effects associated with methamphetamine use. The USA is experiencing increases in methamphetamine use and methamphetamine-related or attributed deaths.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |